Sorry had to change the title guys, some people let the negativity roll.I call from 81 cents to 1.40 a pretty good recovery with more to come over time. A good reason to stay with it or get on.Harlee
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%